心脏瓣膜术后挥发性麻醉药与丙泊酚镇静比较:单中心前瞻性随机对照试验
该单中心前瞻性随机对照试验在三级大学医院纳入开胸瓣膜手术术后患者,随机接受挥发性镇静或丙泊酚镇静,入住ICU后60分钟停用镇静。结果显示挥发性镇静组拔管时间91±39分钟 vs 丙泊酚组167±77分钟(p<0.001),睁眼时间86±28分钟 vs 151±71分钟(p<0.001),遵嘱时间93±38分钟 vs 164±75分钟(p<0.001)。挥发性镇静增加中位9:56分钟(±4:16分钟)的准备时间,两组并发症无差异,体外循环时间无差异。作者认为挥发性镇静虽增加数分钟准备时间,但能加速脆弱患者群体的评估,是安全的镇静技术。
要点
- 心脏瓣膜术后挥发性镇静较丙泊酚显著提前拔管:91±39分钟 vs 167±77分钟(p<0.001)。
- 挥发性镇静组睁眼时间86±28分钟 vs 丙泊酚组151±71分钟(p<0.001),遵嘱时间93±38分钟 vs 164±75分钟(p<0.001)。
- 挥发性镇静增加中位9:56分钟(±4:16分钟)的准备时间。
- 两组并发症无差异,体外循环时间无差异:101(IQR 81;113)分钟 vs 112(IQR 79;136)分钟,p=0.36。
- 作者认为挥发性镇静是安全的镇静技术,可加速脆弱患者群体的评估。
适用人群与场景
- 三级大学医院开胸瓣膜手术术后患者,入住ICU进行术后监护。
处置流程与药物剂量
- 术后入住ICU后60分钟停用镇静,比较挥发性镇静与丙泊酚镇静。
研究设计与关键结果
- 单中心前瞻性随机对照试验,纳入开胸瓣膜手术患者,随机接受挥发性镇静或丙泊酚镇静。
- 拔管时间:挥发性镇静组91±39分钟 vs 丙泊酚组167±77分钟,p<0.001。
- 睁眼时间:挥发性镇静组86±28分钟 vs 丙泊酚组151±71分钟,p<0.001。
- 遵嘱时间:挥发性镇静组93±38分钟 vs 丙泊酚组164±75分钟,p<0.001。
- 挥发性镇静组准备时间中位9:56分钟(±4:16分钟)。
- 两组并发症无差异。
- 体外循环时间:挥发性镇静组101(IQR 81;113)分钟 vs 丙泊酚组112(IQR 79;136)分钟,p=0.36。
证据类型、等级与局限
- 证据类型:单中心前瞻性随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为挥发性镇静虽增加数分钟准备时间,但能加速脆弱患者群体的评估,是安全的镇静技术。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Optimal intensive care of patients undergoing valve surgery is a complex balancing act between sedation for monitoring and timely postoperative awakening. It remains unclear, if these requirements can be fulfilled by volatile sedations in intensive care medicine in an efficient manner. Therefore, this study aimed to assess the time to extubation and secondary the workload required.
METHODS: We conducted a prospective randomized single-center trial at a tertiary university hospital to evaluate the postoperative management of open valve surgery patients. The study was randomized with regard to the use of volatile sedation compared to propofol sedation. Sedation was discontinued 60 min after admission for critical postoperative monitoring.
RESULTS: We observed a significantly earlier extubation (91 ± 39 min vs. 167 ± 77 min; p < 0.001), eye-opening (86 ± 28 min vs. 151 ± 71 min; p < 0.001) and command compliance (93 ± 38 min vs. 164 ± 75 min; p < 0.001) using volatile sedation, which in turn was associated with a significantly increased workload of a median of 9:56 min (± 4:16 min) set-up time. We did not observe any differences in complications. Cardiopulmonary bypass time did not differ between the groups 101 (IQR 81; 113) versus 112 (IQR 79; 136) minutes p = 0.36.
CONCLUSIONS: Using volatile sedation is associated with few minutes additional workload in assembling and enables a significantly accelerated evaluation of vulnerable patient groups. Volatile sedation has considerable advantages and emerges as a safe sedation technique in our vulnerable study population.
TRIAL REGISTRATION: Clinical trials registration (NCT04958668) was completed on 1 July 2021.
参考来源
- Flinspach AN, Raimann FJ, Kaiser P, et al. Volatile versus propofol sedation after cardiac valve surgery: a single-center prospective randomized controlled trial. Crit Care. 2024. PMID: 38581030. doi:10.1186/s13054-024-04899-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。